For full conference registrants only. Not eligible for CME credit unless otherwise noted. Admission requires scanning your name badge. By attending, you consent to sharing your contact information.
2:30 PM – 3:15 PM
Translating Clinical Data: An Overview of JASCAYD® (nerandomilast) Tablets
Sponsored by: Boehringer Ingelheim
Speaker: Lisa Kopas, MD
Room: Ponce 1&2
6:35 PM – 7:20 PM
A Novel Inhaled Maintenance Treatment of COPD-Current Program Objectives/Highlights
Sponsored by: Merck
Speaker: Fortune Alabi, MD
Room: Ponce 1&2
6:55 AM - 7:40 AM
Type 2 Inflammation and the Lungs: Implications for Chronic Obstructive Pulmonary Disease (COPD) and Asthma
Sponsored by: Sanofi & Regeneron
Speaker: Dr. Mario Castro
Room: Ponce 1&2
Breakfast Served
Advancing Care in Patients with NCFB
Sponsored by: Insmed
Speaker: Dr. Juzar Ali
Room: Ponce 3
Breakfast Served
12:35 PM - 1:20 PM
Two Disease One Dupixent
Sponsored by: Sanofi & Regeneron
Speaker: Dr. Jacqueline B. Sutter, DO, FCCP
Room: Ponce 1&2
Lunch Served
The Duality of IL-33 in COPD: Inflammation and Mucus Dysfunction
Sponsored by: AstraZeneca
Speaker: Nicola Hanania, MD
Room: Ponce 3
Lunch Served
6:55 AM - 7:40 AM
One Approach, Many Patients: Addressing Eosinophilic Inflammation
Sponsored by: AstraZeneca
Speakers: Nader Mahmood, MD and Maria Mascolo, MD
Room: Ponce 1&2
Breakfast Served
**Preparing for the Biosimilar Era in Allergy and Immunology: Scientific Principles, Clinical Evidence, and Implications for Patient Care
Supported by an educational grant from Celltrion
Accredited for 1 CME/CE credit
Speakers: coming soon
Room: Ponce 3
Breakfast Served
12:35 PM - 1:20 PM
Addressing Epithelial-Driven Inflammation in Severe Asthma: A Case-Based Approach
Sponsored by: Amgen / AstraZeneca
Speakers: Hemal Mehta, MD and Alexis Smith, DO
Room: Ponce 1&2
Lunch Served
Clinical Evidence in Severe Asthma: A Biologic Option for Patients with an Eosinophilic Phenotype
Sponsored by: GSK
Speaker: Sujoy Gill, MD
Room: Ponce 3
Lunch Served
7:25 AM - 8:10 AM
Inflammation in COPD: From Emerging Evidence to Clinical Practice
Sponsored by: GSK
Speaker: coming soon
Room: Ponce 1&2
Breakfast Served
Triple Therapy in Focus: Tailored Approaches to Obstructive Lung Disease
Sponsored by: AstraZeneca
Speakers: Reynold Panettieri, Jr, MD and Kathleen Dass, MD
Room: Ponce 3
Breakfast Served
**This product theater is organized and provided independently by Celltrion and is separate from the ACAAI jointly provided educational activity. Participation in this product theater does not count towards the AMA PRA Category 1 Credits™ designated by ACAAI. Any CME credit associated with this session is offered solely from Celltrion and is subject to its own accreditation and credit designation statements.
For review articles and abstracts from EPC, visit the Journal of Precision Respiratory Medicine
© 2026 EPC. All rights reserved.